Will the ZyCov-D's DNA vaccine against Covid-19 be approved by either the FDA or EMA in 2021?
Market Rules
India's drug regulatory agency has approved the emergency use of a new vaccine against COVID-19 (ZyCoV-D), developed by Indian pharmaceutical company Zydus Cadila. The major innovation of this vaccine is that its immunizing agent is made from DNA, does not require the use of needles, and can be stored at higher temperatures (from - 2 °C to 8 °C).
The DNA used in the vaccine contains information for human cells to build the protein that the coronavirus uses to invade human body cells. When producing this protein, the immune system starts to produce antibodies, which can fight the actual virus if it is eventually detected in the body.
If the ZyCoV-D vaccine is approved for use by either one of the following health regulation agencies - FDA (USA) EMA (European Union) - by the end of 2021, this market will resolve to “Yes”.